Clari Vest Asset Management LLC Avid Bioservices, Inc. Transaction History

Clari Vest Asset Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$16.63 - $27.73 $604,467 - $1.01 Million	-36,348 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$20.7 - $34.18 $980,455 - $1.62 Million	-47,365 Reduced 56.58%	36,348 $1.06 Million
Q3 2021 Nov 08, 2021	SELL	$19.05 - $28.32 $35,852 - $53,298	-1,882 Reduced 2.2%	83,713 $1.81 Million
Q2 2021 Aug 09, 2021	SELL	$18.93 - $25.65 $499,922 - $677,390	-26,409 Reduced 23.58%	85,595 $2.2 Million
Q1 2021 May 13, 2021	BUY	$11.86 - $21.77 $16,604 - $30,478	1,400 Added 1.27%	112,004 $2.04 Million
Q4 2020 Feb 09, 2021	SELL	$7.25 - $11.76 $423,827 - $687,477	-58,459 Reduced 34.58%	110,604 $1.28 Million
Q3 2020 Nov 09, 2020	SELL	$6.53 - $8.6 $246,011 - $323,996	-37,674 Reduced 18.22%	169,063 $1.29 Million
Q2 2020 Aug 12, 2020	SELL	$4.11 - $6.78 $96,054 - $158,455	-23,371 Reduced 10.16%	206,737 $1.36 Million
Q1 2020 May 04, 2020	BUY	$3.15 - $7.39 $238,858 - $560,368	75,828 Added 49.15%	230,108 $1.18 Million
Q4 2019 Feb 12, 2020	BUY	$5.01 - $8.16 $772,942 - $1.26 Million	154,280 New	154,280 $1.18 Million

183

67.8M

89.9K

118K

Ticker CDMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,167,500
Market Cap $763M
Description
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.